Congress

As 2006 comes to an end, we look back to find the most significant victories and advances for drug reform this year.

Congress has passed a measure that will allow for the testing of potentially dangerous mycoherbicides to be used to destroy illicit drug crops. But in a victory for reformers, the okay will be limited to labs in the US -- not fields in Latin America.

Congress last Friday moved to expand the number of patients certified physicians can treat with buprenorphine for opiate addiction. This is the second increase in two years.

Will Democratic control of the Congress mean significant drug reform progress next year? Drug reformers certainly hope so, but the prospects are uncertain.

In the wake of a trio of high-profile police killings of civilians, African-American civil rights activist the Rev. Al Sharpton is calling for congressional hearings on police violence.

Harm reduction advocates are looking to the new Congress with hope.

Students for Sensible Drug Policy held its annual conference in Washington, DC, last weekend. Here's our report.

DRCNet's executive director offers a brief analysis of the new political dynamic in Washington as it affects drug policy.

Today marks a grim anniversary in US drug policy, the enactment 20 years ago of unjust federal mandatory minimum sentences.

If law enforcers stage a high-profile drug bust with the intention of influencing the outcome of the legislative process, is it lobbying?